HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Old Spice Hardest Working Campaign Reflects P&G Focus On Core Brands

This article was originally published in The Rose Sheet

Executive Summary

P&G's new Old Spice Hardest Working Collection line of antiperspirants/deodorants boasts a higher level of the brand’s beta-cyclodextrin odor-fighting technology. The line, also including a body wash, is supported by a multidimensional campaign featuring a new ad personality, "Legendary Man."

You may also be interested in...



P&G Extends Secret Line With Essential Oils, Challenges 'Sweat' With Old Spice

P&G rolls out Secret with Essential Oils with aluminum zirconium tetrachlorohydrex glycine 15, retailing at more than twice price of other Secret antiperspirant/deodorant lineup items. Firm also adds "No Sweat" ad campaign for Old Spice deodorants.

P&G Refocusing Olay Innovation As Brand Revival Continues

P&G leadership discussed the firm’s ongoing efforts to reinvigorate Olay, the only major brand in its skin and personal-care segment that has not grown over the past four years, during a Nov. 18 Analyst Day presentation.

P&G Enters FY 2017 With Pressure To Execute In Line With Promises

Increased R&D and ad spending, improved consumer communications and other brand-building investments will enable P&G to grow and recapture market share in fiscal 2017, company leadership suggests. While the stage may be set for P&G to “get the belt back,” as one analyst suggests, all are watching for execution.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019997

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel